A Comparison of Direct Sequencing and ARMS Assay Performance in EGFR Mutation Analysis of Non-small Cell Lung Cancer Patients

A Comparison of Direct Sequencing and ARMS Assay Performance in EGFR Mutation Analysis of Non-small Cell Lung Cancer Patients

Background and objective Epidermal growth factor receptor (EGFR) inhibitors are mainly used for the targeted therapy of non-small cell lung cancer (NSCLC). Therefore, EGFR mutations should be detected to treat lung cancer. The aim of this study is to determine the detection rate of NSCLC in patients...

Full description

Bibliographic Details
Main Authors: Chenchen LI, Jianzhong WU, Zhuo WANG, Jifeng FENG
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2014-08-01
Series:Chinese Journal of Lung Cancer
Subjects:
EGFR mutation
Direct sequencing
ARMS
Lung neoplasms
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2014.08.05

Internet

http://dx.doi.org/10.3779/j.issn.1009-3419.2014.08.05

Similar Items